MedTrace Logo

The CATALINA Study

NCT05008081 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2026-05-22

No results posted yet for this study

Summary

The CATALINA study is a prospective cohort study embedded within CICERO (Collaboration In COPD ExaceRbatiOns, a European Respiratory Society supported Clinical Research Collaboration), designed to collect standardised, longitudinal clinical data and biological samples in 20 centres across Europe and beyond.

Conditions

  • Chronic Obstructive Pulmonary Disease Exacerbation

Sponsors & Collaborators

  • European Respiratory Society

    collaborator OTHER

  • AstraZeneca

    collaborator INDUSTRY

  • Roche Pharma AG

    collaborator INDUSTRY

  • GlaxoSmithKline

    collaborator INDUSTRY

  • Wim Janssens

    lead OTHER

Principal Investigators

  • Wim Janssens, MD, PhD · UZ/KU Leuven - Belgium

  • Mona Bafadhel, MD, PhD · King's College London - UK

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-25
Primary Completion
2027-03-31
Completion
2028-03-31

Countries

  • Austria
  • Belgium
  • France
  • Germany
  • Italy
  • Netherlands
  • Slovenia
  • Spain
  • Sweden
  • Turkey (Türkiye)
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05008081 on ClinicalTrials.gov